000 | 01089 a2200325 4500 | ||
---|---|---|---|
005 | 20250516205107.0 | ||
264 | 0 | _c20141203 | |
008 | 201412s 0 0 eng d | ||
022 | _a1790-6245 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeidle, Ulrich H | |
245 | 0 | 0 |
_aProteases as activators for cytotoxic prodrugs in antitumor therapy. _h[electronic resource] |
260 |
_bCancer genomics & proteomics _c |
||
300 |
_a67-79 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xmetabolism |
650 | 0 | 4 |
_aCathepsin B _xphysiology |
650 | 0 | 4 |
_aGranzymes _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMatrix Metalloproteinases _xphysiology |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aProdrugs _xmetabolism |
650 | 0 | 4 | _aProteolysis |
650 | 0 | 4 |
_aSerine Endopeptidases _xphysiology |
650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xphysiology |
700 | 1 | _aTiefenthaler, Georg | |
700 | 1 | _aGeorges, Guy | |
773 | 0 |
_tCancer genomics & proteomics _gvol. 11 _gno. 2 _gp. 67-79 |
|
999 |
_c23715483 _d23715483 |